or Try an Advanced Search...

    ETF Components for BMED - BlackRock Future Health ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    COR C -4.12 3.21
    BSX A 0.47 3.07
    ISRG C 0.29 2.30
    ALGN F 0.76 2.24
    COO D 0.67 2.23
    WST D 1.66 2.21
    ABBV D -0.57 2.11
    AMGN B 1.25 1.88
    BMRN D 3.18 1.77

    Represented by ETF Holdings

    Keywords: S&P 500 Medicine Nasdaq 100 Autoimmune Disease Clinic Endoscopy Pharmaceutical 3 D Ablation Achondroplasia Adalimumab Administration Systems Advanced Prostate Cancer Anemia Angiography Angioplasty Artery Artery Disease Artificial Cardiac Pacemaker Aspheric Lens
    Industries: Medical Instruments & Supplies Drug Manufacturers - Major Medical Devices Biotechnology Medical Distribution

    Recent News for BlackRock Future Health ETF & its Holdings

    Date Stock Title
    May 1 ABBV CVS stock plunges after earnings numbers one analyst 'did not even believe'
    May 1 AMGN CytomX surges on upcoming data for Amgen-partnered cancer drug
    May 1 COR Cencora, Inc. 2024 Q2 - Results - Earnings Call Presentation
    May 1 BSX Cencora (COR) Q2 Earnings Top Estimates, 2024 View Raised
    May 1 AMGN Amgen investors await weight-loss drug data
    May 1 AMGN AMGEN HIGHLIGHTS NEW COPD, ASTHMA AND VASCULITIS RESEARCH AT ATS 2024
    May 1 COR Cencora Reports Fiscal 2024 Second Quarter Results
    May 1 COR Cencora Non-GAAP EPS of $3.80 beats by $0.11, revenue of $68.4B misses by $2.36B
    Apr 30 COO CooperCompanies Announces Release Date for Second Quarter 2024
    Apr 30 BSX Boston Scientific Shares Tracking Higher
    Apr 30 AMGN Sandoz Settles Patent Dispute With Amgen Related To Bone Disorder Drug Denosumab
    Apr 30 BSX Ecolab (ECL) Q1 Earnings Surpass Estimates, Margins Rise
    Apr 30 ALGN Ecolab (ECL) Q1 Earnings Surpass Estimates, Margins Rise
    Apr 30 BSX QIAGEN (QGEN) Q1 Earnings Top Estimates, Margins Expand
    Apr 30 ABBV Trials to watch: Four ALS drugs to keep an eye on
    Apr 30 ABBV AbbVie (ABBV) Could Be a Great Choice
    Apr 30 COR Cencora Q2 2024 Earnings Preview
    Apr 30 AMGN Will These 5 Drug/Biotech Stocks Beat Q1 Earnings Forecast?
    Apr 30 WST West Pharmaceutical Services, Inc. (NYSE:WST) Q1 2024 Earnings Call Transcript
    Apr 30 ABBV AbbVie Inc. (NYSE:ABBV) Q1 2024 Earnings Call Transcript
    The investment seeks to maximize total return. Under normal market conditions, the fund will invest at least 80% of its net assets plus any borrowings for investment purposes in equity securities of companies principally engaged in the health sciences group of industries. While the fund will invest primarily in companies providing products and services for human health, it may also invest in companies whose products or services relate to the growth or survival of animals and plants. The fund is non-diversified.
    Private Equity Investment Management Petroleum & Resources Corporation
    Back to the Main BMED Page...